EWTX
Edgewise Therapeutics Inc
Price:  
29.46 
USD
Volume:  
592,200.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EWTX WACC - Weighted Average Cost of Capital

The WACC of Edgewise Therapeutics Inc (EWTX) is 5.8%.

The Cost of Equity of Edgewise Therapeutics Inc (EWTX) is 7.60%.
The Cost of Debt of Edgewise Therapeutics Inc (EWTX) is 5.00%.

Range Selected
Cost of equity 6.10% - 9.10% 7.60%
Tax rate 22.10% - 22.30% 22.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.0% - 6.5% 5.8%
WACC

EWTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.5 0.76
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 9.10%
Tax rate 22.10% 22.30%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.0% 6.5%
Selected WACC 5.8%